<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000727.v1.p1" parentStudy="phs000727.v1.p1" createDate="2014-03-17" modDate="2014-11-04">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Kendall Van Keuren-Jensen, PhD</td><td>The Translational Genomics Research Institute (TGen), Phoenix, AZ, USA</td></tr>
		<tr><td>Funding Source</td><td>Rapid Response Innovation Award</td><td>Michael J. Fox Foundation for Parkinson&#39;s disease, New York, NY, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>miRNA profiles in serum and CSF of Parkinson&#39;s and Alzheimer&#39;s patients</StudyNameEntrez>
	<StudyNameReportPage>Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer&#39;s or Parkinson&#39;s disease correlate with disease status and features of pathology</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>We profiled the miRNA contents from cerebrospinal fluid and serum (using next generation sequencing) from postmortem patients diagnosed with Alzheimer&#39;s or Parkinson&#39;s disease, and neurologically normal controls. All biofluids were cell-free and patient matched, there was one cerebrospinal fluid and one serum sample from each of 70 patients with Alzheimer&#39;s disease, 67 patients with Parkinson&#39;s disease and 78 age-similar controls. We correlated the miRNA changes with measurements of neuropathology such as plaques, tangles and Lewy bodies.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>For inclusion in the study, the participants had to be diagnosed with Alzheimer&#39;s disease or Parkinson&#39;s disease based on postmortem neuropathological criteria or to be neuropathologically normal.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="24797360"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Alzheimer Disease"/>
		<Disease vocab_source="MESH" vocab_term="Parkinson Disease"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Kendall Van Keuren-Jensen, PhD</AttName>
			<Institution>The Translational Genomics Research Institute (TGen), Phoenix, AZ, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>Rapid Response Innovation Award</AttName>
			<Institution>Michael J. Fox Foundation for Parkinson&#39;s disease, New York, NY, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyURLs>
		<Url name="michaeljfox" url="https://www.michaeljfox.org/"/>
		<Url name="tgen" url="https://tGen.org"/>
	</StudyURLs>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NINDS</DacName>
      <DacFullName>National Institute of Neurological Disorders and Stroke</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000727.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000727.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000727.v1.p1" FileName="1D2C27A.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
